Starting from:

$24500

Sorbitol Dehydrogenase Deficiency (U.S.), New

MarketVue®: Sorbitol Dehydrogenase (SORD) Deficiency


The MarketVue®: Sorbitol Dehydrogenase (SORD) Deficiency market landscape report combines primary (KOL interviews) and secondary market research to empower strategic decision-making and provide a complete view of the market.

Every MarketVue® includes a disease overview, epidemiology (US), current treatment, unmet needs, pipeline and access and reimbursement chapter.